Kane Biotech Announces Loan Transaction
December 29, 2022 17:34 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has reached an agreement to obtain loans...
PDS Biotech Reports Median Overall Survival (OS) of 21 Months in Advanced, Refractory Cancer Patients Having Few Remaining Treatment Options and with Reported Historical Survival of 3-4 months
December 28, 2022 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Dec. 28, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
$38 Billion Worldwide Digital Biomanufacturing Industry to 2030 - Players Include 3M, ABB, Cytiva, Siemens, Immersciobio and Sanofi
December 27, 2022 05:23 ET
|
Research and Markets
Dublin, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report has been...
Otonomy Announces Change in Stock Exchange Listing
December 22, 2022 07:53 ET
|
Otonomy, Inc.
SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq)...
Single Use Bioprocessing Global Market Report 2022: Featuring GE Healthcare, Merck, Thermo Fisher Scientific, JM BioConnect & More
December 22, 2022 06:58 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Single Use Bioprocessing Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.The global...
Lilly and ProQR to Expand RNA Editing Collaboration
December 22, 2022 06:00 ET
|
ProQR Therapeutics N.V.
INDIANAPOLIS; LEIDEN, Netherlands; and CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics N.V. (Nasdaq: PRQR), today announced the expansion...
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
December 21, 2022 16:15 ET
|
Madrigal Pharmaceuticals, Inc.
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing CapacityMadrigal intends to submit a new drug application for resmetirom in the first half of 2023 CONSHOHOCKEN,...
UAT Group’s Subsidiary, H2O Processing, Enters into Agreement to Acquire Discharge Well Interest Valued at $2.8M Annually
December 21, 2022 07:45 ET
|
Umbra Applied Technologies Group, Inc.
Denver, CO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) subsidiary, H2O Processing, announced today that it has entered into an agreement with Bellows...
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
December 20, 2022 19:01 ET
|
Sosei Group Corporation
PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2 trial by Pfizer triggers payment of US$10...
Mathias Romacker Selected as the Newest Member of the Kymanox Executive Advisor Team
December 20, 2022 11:36 ET
|
Kymanox
Los Angeles, California, USA and Research Triangle Park, North Carolina, USA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services organization supporting...